Skip to main content
Journal cover image

V-RULES: Impact of Treatment Setting on CPX-351 Safety and Effectiveness in Secondary Acute Myeloid Leukemia

Publication ,  Conference
LeBlanc, TW; Lai, C; Ali, A; Chan, O; Cole, D; Gonzalez-Lugo, JD; Koenig, KL; Lo, M; Newman, MJ; Park, S; Piccoli, G; Francia, R; Wagner, CB ...
Published in: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2025

Duke Scholars

Published In

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

EISSN

2152-2669

ISSN

2152-2650

Publication Date

2025

Volume

25

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
LeBlanc, T. W., Lai, C., Ali, A., Chan, O., Cole, D., Gonzalez-Lugo, J. D., … Wang, E. S. (2025). V-RULES: Impact of Treatment Setting on CPX-351 Safety and Effectiveness in Secondary Acute Myeloid Leukemia. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 25).
LeBlanc, Thomas W., Catherine Lai, Amir Ali, Onyee Chan, Doria Cole, Jesus D. Gonzalez-Lugo, Kristin L. Koenig, et al. “V-RULES: Impact of Treatment Setting on CPX-351 Safety and Effectiveness in Secondary Acute Myeloid Leukemia.” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Vol. 25, 2025.
LeBlanc TW, Lai C, Ali A, Chan O, Cole D, Gonzalez-Lugo JD, et al. V-RULES: Impact of Treatment Setting on CPX-351 Safety and Effectiveness in Secondary Acute Myeloid Leukemia. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2025.
LeBlanc, Thomas W., et al. “V-RULES: Impact of Treatment Setting on CPX-351 Safety and Effectiveness in Secondary Acute Myeloid Leukemia.” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 25, 2025.
LeBlanc TW, Lai C, Ali A, Chan O, Cole D, Gonzalez-Lugo JD, Koenig KL, Lo M, Newman MJ, Park S, Piccoli G, Francia R, Wagner CB, Lopez A, Yaghmour G, Wang ES. V-RULES: Impact of Treatment Setting on CPX-351 Safety and Effectiveness in Secondary Acute Myeloid Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2025.
Journal cover image

Published In

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

EISSN

2152-2669

ISSN

2152-2650

Publication Date

2025

Volume

25

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences